ZHANG JIA JIE JI YUAN BIOTECH CO.,LTD

Company profile

Zhangjiajie Jiyuan Biotech Co., Ltd. was registered and established in November 2014. The registered capital is 80 million yuan. The company is located in Zhangjiajie High-tech industrial Development Zone, is currently the largest citrus extract research and development, production, sales in one of the biomedical enterprises.

The company mainly uses citrus fallen fruit and citrus as raw materials, adopts independent research and development of green, low carbon, efficient plant extraction and preparation technology, production of hesperidin, syneferin, Aurantii flavone and other citrus extracts, the products are mainly used in medicine, food and other health industry.

Companies relying on big wuling area rich plant resources, actively response to the country and hunan province "much starker choices-and graver consequences-in" strategic new industry development planning, positioning for extracting effective components from natural plants, development of efficient forward industrial biocatalysis technology system, promote green biotechnology applications, realize large-scale production, medicine and chemical intermediate, since the company set up After seven years of continuous efforts, the company has won a series of honors such as national high-tech Enterprise, Hunan New Material Enterprise, Hunan Little Giant enterprise, Zhangjiajie Advanced Enterprise in science and technology innovation, tax ten million star award and so on.

Green manufacturing helps farmers to generate income

   One of the main products of the company is hesperidin, which is a medical raw material used for cardiovascular health care. It is mainly used as an API for the production of diosamine. At present, it can only be extracted from IMmaturus aurantii and cannot be synthesized artificially. The international demand is more than 3000 tons per year. At present, the company's hesperidin series products occupy 45% of the international market, ranking first in Hunan Province.

Since it was officially put into operation in November 2018, through the implementation and industrialization of the production line with an annual output of 1,500 tons of hesperidin, the production line with an annual output of 40 tons of syneferine and the upgrading and transformation of joint extraction technology, it has produced nearly 3,000 tons of products with an output value of about 350 million yuan. Among them, 21,500 tons of raw materials were purchased and consumed, and 235 million yuan of the purchase cost was distributed to citrus farmers. These raw materials are the physiological fruit of citrus, which cannot produce economic benefits. Through the development of citrus fruit farmers to collect and process citrus fruit, provide our company with raw materials for production, so that the waste has been reused, in line with the national vigorously advocated "green circular economy" requirements. Through "orchard to herbal garden", which can effectively relieve the contradictions of citrus production and marketing, improve the economic value of existing perform, benefit the masses of orange farmers, to expand the orange farmer selling agricultural products market, has great economic benefits, to drive the wuling mountain area and national citrus fruit production of producing revenue, and the crucial results consolidate out of poverty has played a large role, At the same time to accelerate the pace of rural revitalization construction in our province, the realization of common prosperity strategy made a contribution.

Through citrus plant extraction, the company can provide a demonstration for the comprehensive utilization and transformation and upgrading of bulk agricultural resources, which opens up a bigger space for the development and expansion of China's vast plant extraction industry, and will promote the structural adjustment and industrial transformation and upgrading of our province's citrus industry, and extend and innovate the citrus industry chain. It will make citrus industry in our province become a strategic emerging health industry with good economic benefit and strong driving effect.